OMOP has built a library of methods, developed for the OMOP Common Data Model, to address the analysis problems of Monitoring of Health Outcomes of Interest and Identification of Non-Specified Conditions. These methods are tested across the OMOP Data Community. These methods are available under the Apache public license.

If you would like to contribute to the methods, please contact OMOP by adding a new comment below.

Methods in 2011

The links below contain source code and instructions on how to execute these methods.

• Bayesian Multiple Self-Controlled Case Series (MSCCS) Analysis program - Columbia University 05 July 2011 Released

---




OMOP PHASE 3 Methods for Evaluation

The links below contain source code and instructions for the OMOP Distributed Partners on how to execute these methods for the Phase 3 performance measurement experiments.

• Disproportionality Analysis - OMOP Research Team 15 March 2010 Released - Updated 2 May 2010
• Univariate Self-Controlled Case Series - OMOP Research Team 2 April 2010 - Updated 4 September 2010
• Observational Screening - ProSanos Corporation 8 April 2010 - Updated 19 September 2010
• Multi-Set Case Control Estimation - OMOP Research Team 16 April 2010
• Bayesian Logistic Regression - OMOP Research Team 21 April 2010 - Updated on 14 May 2010
• Case Control Surveillance - Lilly 2 May 2010 - Updated on 14 May 2010
• IC Temporal Pattern Discovery - Uppsala Monitoring Centre 23 May 2010
• Case-Crossover - University of Utah 01 June 2010
• HSIU Population-Based Method - Indiana University 08 June 2010
• Maximized Sequential Probability Ratio Test (MSPRT) - Harvard Pilgrim Health Care 25 July 2010 - Updated 24 September 2010
• High-Dimensional Propensity Score (HDPS) - OMOP Research Team 06 August 2010
• Conditional Sequential Sampling Procedure (CSSP) - Harvard Pilgrim Health Care 30 August 2010 - Updated 24 September 2010
• Incident User Design (IUD-HOI) - M. Alan Brookhart 26 October 2010
• Longitudinal Gamma Poisson Shrinker (LGPS) & Longitudinal Evaluation of Observational Profiles of Adverse events Related to Drugs (LEOPARD) - Martijn Schuemie;Erasmus University Medical Center Rotterdam 20 January 2011

---




OMOP PHASE 2 Methods for Feasibility Testing

The links below contain source code, specifications, and test cases used by the Distributed Partners during the Phase 2 feasibility testing.

Guidelines

• OMOP Methods development guidelines

Regularized Identification of Cohorts (RICO) - ProSanos Corporation

• RICO Oracle 10March 2010
• RICO HOI SQL Calls 10March 2010
• RICO SAS 24March 2010
• RICO SAS HOI Calls 10March 2010